Delivery Order SPE2DB24D2100-SPE2DB25FBCNY

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse 50 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,897.86 and is a Firm Fixed Price Delivery Order that runs through January 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 10 mg Vyvanse capsules to the Defense Logistics Agency (DLA). The contract, valued at $5,072.74, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2025. It is not a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Vyvanse capsules 30mg to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The one-year contract has a ceiling value of $8,332.56 and is a firm-fixed-price delivery order. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, and has a ceiling value of $1,225.66. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of Vyvanse 70 mg capsules in quantities of 100s to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,679.30 and runs through February 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly the military and veterans' healthcare systems. The contract is a Firm Fixed Price Delivery Order and...
This federal contract award is for the delivery of Vyvanse 40 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $2,840.10 and an ultimate completion date of October 23, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This federal contract award is for the delivery of Vyvanse 40 mg capsules (100-count bottles) to the Defense Logistics Agency (DLA), a defense agency. The $1,337.70 firm-fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,564.56. The contract has an ultimate completion date of July 9, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $2,424.96 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 3, 2022, with a completion date of November 6, 2023. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBCNY
    Delivery Order

This federal contract award is for the delivery of Vyvanse 50 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm-fixed-price delivery order contract with a ceiling value of $1,963.84 and a period of performance through March 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/2/25, 9:49 AM